Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Microfluidic chip technology integrates basic operational units such as sample preparation, reaction, analysis, and detection, harnessing techniques from the fields of chemistry and biology into a chip of several square centimeters, automatically completing the entire analysis process.

Recently AmoyDx ROS1 gene fusion detection kit (fluorescence PCR method) was approved by Taiwan Food and Drug Administration（TFDA). Prior to this, the AmoyDx ROS1 Gene Fusion Detection Kit has been approved by China NMPA, Japan PMDA and Ko

Foundation Medicine announced recently that its FoundationOne CDx genomic profiling assay has received regulatory approval from Japans Ministry of Health, Labour and Welfare (MHLW). The next-generation sequencing-based assay which was appro

Cepheid announced recently it has received CE-IVD clearance for a rapid molecular assay to measure viral load of hepatitis B in infected patients. The Xpert HBV Viral Load test measures HBV DNA levels in plasma or serum using the firms Gene

French diagnostics firm Novacyt announcedrecentlythat it has received CE marking for its Genesig BK virus (BKV) and Epstein-Barr virus (EBV) diagnostic kits, which are designed for use in post-transplantation and immunosuppressed patients. B

A cell-by-cell search for cardiac stem cells has come up empty, suggesting that previous studies hinting at the existence of cardiac stem cells were mistaken. More significantly, the absence of cardiac stem cells indicates that heart muscle

An innovative new medical instrumentation and biotechnology company known asDaxorjust published some exciting new data for their flagship technology, theBVA-100 blood volume analyzer. The new technology is designed to quantify circulating to

Oxford HighQ has received2.1 millionin seed funding to commercialize components of a quantum computing technology developed at Oxford University that can be used to develop improved chemical and nanoparticle sensing technologies. Oxford High

A long-awaited and massive study with major implications for the liquid biopsy market is slated to start next year. Earlier this week, GRAIL revealed that it would initiate its 50,000-patient SUMMIT study in early 2019. Ages of the patients

Brigham and Womens Hospital investigators are working on a test that could either diagnose or predict Alzheimers disease before symptoms appear. The investigators approach is in the December issue of Alzheimers Dementia. Tau proteins have lo

At the close of the 2014-2016 West Africa Ebola crisis, the Paul G. Allen Foundation identified diagnostic gaps as one of the major deficiencies that had contributed to the outbreaks spread. The standard diagnostic tests that exist are very